MINNEAPOLIS, March 1 Sunlight Research(TM) - The Source for Patent Analysis (www.sunlightresearch.com) today announced the release of its report analyzing the U.S. human mesenchymal stem cells (MSCs) patent portfolio of Osiris ...
NEW YORK, Feb. 28 Genetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the ...
NEW YORK, Feb. 24 Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated ...
NEW YORK, Feb. 24 Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated ...
SEATTLE, Feb. 24 Isilon® Systems (Nasdaq: ISLN) today announced that SeqWright has deployed Isilon scale-out NAS as an end-to-end storage solution for its full range of next-generation genomic sequencing services. By combining Isilon's ...
HAITI EARTHQUAKE (continued) We've added the following to items posted previously at http:budurl.com/haitiexperts and http:budurl.com/haitiexperts2 1. ELIZABETH DURSO BRANCH, who focuses on child-related issues as a partner at the family law ...
OMAHA, Neb., Feb. 8 Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced today that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect ...
IPSWICH, Mass. , Feb. 4 /PRNewswire/ -- As an important supplier to the Wellcome Trust Sanger Institute, New England Biolabs is pleased to announce that the Sanger Institute will use New England Biolabs as one of its suppliers for ...
First Commercial Test using SEQureDx Technology for Determining Rhesus D Incompatibility SAN DIEGO , Feb. 4 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced the launch of the SensiGene™ Fetal RHD Genotyping test by ...
Collaboration will further evaluate novel stem cell-derived product for the treatment of fatal neurodegenerative disease by regulating genes relevant to disease progression CAMBRIDGE, Mass. and IRVINE, Calif., Feb. 2 ...
New study finds genetic modifiers control human mutation rates, revealing how populations evolve and risk for genetic diseases may vary.
New gene discovery in Fanconi Anemia reveals a more severe form of the disorder and offers fresh insights that could lead to improved treatment options.
A molecular mechanism where impaired tRNA splicing disrupts cranial neural crest cells, revealing MYCN, DDX1, and tRNA processing defects as risk factors for orofacial clefts.
Genetic analysis reveals that dire wolves are not gray wolves’ ancestors but a separate species, reshaping evolutionary knowledge after 12,500 years.
A faulty FLCN gene may affect 1 in 3,000 people, raising their risk of pneumothorax, but shows a much lower kidney cancer risk.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers